News Features Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing Shelley Wood January 04, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF Shelley Wood November 16, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Daily News Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows Michael O'Riordan September 30, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Daily News Precious Time: Questionable Treatments Often Used at the End of Life Todd Neale June 30, 2016
News Industry News Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure June 13, 2016
News Industry News Medtronic Receives FDA Approval for New Single-Chamber ICDs That Detect Atrial Fibrillation May 02, 2016
News Daily News Percutaneous Interatrial Shunts May Offer New Hope for Advanced Heart Failure Patients L.A. McKeown March 29, 2016
News Daily News Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs Michael O'Riordan March 25, 2016
News Industry News Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators February 04, 2016
News Daily News Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure Michael O'Riordan January 19, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Industry News Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure October 27, 2015
News Industry News Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure October 26, 2015